Showing results (21-30 of 51) with videos related to
Sort By:
Pageof 6
Oncogene|October 19, 1995
Upregulation of vascular endothelial growth factor (VEGF) and downregulation of placenta growth factor (PlGF) associated with malignancy in human thyroid tumors and cell linesG Viglietto, D Maglione, M Rambaldi, et al.British Journal of Cancer|December 4, 2003
An increased high-mobility group A2 expression level is associated with malignant phenotype in pancreatic exocrine tissueN Abe, T Watanabe, Y Suzuki, et al.Cancer Research|June 24, 2000
Pancreatic duct cell carcinomas express high levels of high mobility group I(Y) proteinsN Abe, T Watanabe, T Masaki, et al.Cancer Research|April 15, 1996
Human colorectal carcinomas express high levels of high mobility group HMGI(Y) proteinsM Fedele, A Bandiera, G Chiappetta, et al.International Journal of Cancer|June 22, 1995
Expression of galectin-1 in normal human thyroid gland and in differentiated and poorly differentiated thyroid tumorsL Chiariotti, M T Berlingieri, C Battaglia, et al.Cancer Research|November 15, 1993
Production of transgenic mice expressing the Ki-ras oncogene under the control of a thyroglobulin promoterG Santelli, V de Franciscis, G Portella, et al.Oncogene|April 18, 1996
Development of thyroid papillary carcinomas secondary to tissue-specific expression of the RET/PTC1 oncogene in transgenic miceM Santoro, G Chiappetta, A Cerrato, et al.The Journal of Clinical Endocrinology and Metabolism|November 4, 2000
Tyrosines 1015 and 1062 are in vivo autophosphorylation sites in ret and ret-derived oncoproteinsD Salvatore, M V Barone, G Salvatore, et al.International Journal of Oncology|March 16, 2000
Glial cell line-derived neutrotrophic factor and neurturin can act as paracrine growth factors stimulating DNA synthesis of Ret-expressing spermatogoniaG Viglietto, S Dolci, P Bruni, et al.Oncogene|September 21, 1995
RET/PTC oncogene activation is an early event in thyroid carcinogenesisG Viglietto, G Chiappetta, F J Martinez-Tello, et al.Pageof 6